• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核病相关慢性阻塞性肺疾病的发病率及危险因素

Incidence and Risk Factors of Tuberculosis-Associated Chronic Obstructive Pulmonary Disease.

作者信息

Joo Dong-Hyun, Kim Min Chul, Sin Sooim, Kang Hye-Rin, Song Jin Hwa, Kim Hyung-Jun, Song Myung Jin, Kwon Byoung Soo, Kim Yeon Wook, Lee Yeon Joo, Park Jong Sun, Lee Jae Ho, Lee Ye Jin

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, National Medical Centre, Seoul, Republic of Korea.

出版信息

Int J Chron Obstruct Pulmon Dis. 2025 Jun 26;20:2091-2102. doi: 10.2147/COPD.S523732. eCollection 2025.

DOI:10.2147/COPD.S523732
PMID:40589917
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12208119/
Abstract

PURPOSE

Chronic obstructive pulmonary disease (COPD) is influenced by multiple factors. Varying prevalences of tuberculosis-associated COPD exist. However, studies on its incidence or risk factors are limited. We evaluated the incidence of tuberculosis-associated COPD and compare the characteristics of patients with and without COPD.

PATIENTS AND METHODS

This multicenter, retrospective cohort study included 351 patients treated with anti-tuberculosis drugs for more than 6 months in four hospitals in Korea, followed for 11 years (132 months). The follow-up duration was divided into quartiles (Q1-Q4) to evaluate the change in the incidence of COPD over time. Clinical data and radiological findings were collected, and the incidence rate ratios were compared using Poisson regression and multivariable logistic regression analysis to identify risk factors.

RESULTS

Overall, 71 participants developed tuberculosis-associated COPD, with an overall crude incidence of 20.56/1000 person-years. Patients with tuberculosis-associated COPD were older, more likely to be smokers, and had lower forced expiratory volume in 1 s (FEV1) (L) and lower FEV1/forced vital capacity. The incidence over 132 months was significantly lower than those during follow-up, with an incidence rate ratio of 0.49 (p=0.027). Multivariate analysis revealed that a tuberculosis diagnosis at an older age (adjusted odds ratio [aOR] 1.04; 95% confidence interval [CI]: 1.01-1.07), lower baseline FEV1 <80% (aOR 3.98; 95% CI: 1.92-8.24), smoking (aOR 3.23; 95% CI: 1.14-9.17), and multilobar involvement of tuberculosis (aOR 2.04; 95% CI: 1.08-3.85) were risk factors for tuberculosis-associated COPD. The incidence in the Q4 (>132 months, approximately 11years) was significantly lower than that in the Q1 (18-71 months), with incidence rate ratio of 0.49 (p= 0.027).

CONCLUSION

Older age at tuberculosis diagnosis, lower baseline FEV1 <80%, smoking history, and multilobar involvement were identified as risk factors for tuberculosis-associated COPD. The incidence of tuberculosis-associated COPD decreased 11 years after tuberculosis treatment.

摘要

目的

慢性阻塞性肺疾病(COPD)受多种因素影响。与结核病相关的COPD患病率各不相同。然而,关于其发病率或危险因素的研究有限。我们评估了与结核病相关的COPD的发病率,并比较了有和没有COPD的患者的特征。

患者与方法

这项多中心回顾性队列研究纳入了韩国四家医院中接受抗结核药物治疗超过6个月的351例患者,随访11年(132个月)。将随访时间分为四分位数(Q1-Q4)以评估COPD发病率随时间的变化。收集临床数据和影像学检查结果,并使用泊松回归和多变量逻辑回归分析比较发病率比,以确定危险因素。

结果

总体而言,71名参与者患上了与结核病相关的COPD,总体粗发病率为20.56/1000人年。与结核病相关的COPD患者年龄较大,更可能是吸烟者,且第1秒用力呼气量(FEV1)(升)较低,FEV1/用力肺活量也较低。132个月期间的发病率明显低于随访期间,发病率比为0.49(p=0.027)。多变量分析显示,年龄较大时诊断为结核病(调整优势比[aOR]1.04;95%置信区间[CI]:1.01-

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d5d/12208119/18d07bb0a4b5/COPD-20-2091-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d5d/12208119/ed99afd3cd92/COPD-20-2091-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d5d/12208119/18d07bb0a4b5/COPD-20-2091-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d5d/12208119/ed99afd3cd92/COPD-20-2091-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d5d/12208119/18d07bb0a4b5/COPD-20-2091-g0002.jpg

相似文献

1
Incidence and Risk Factors of Tuberculosis-Associated Chronic Obstructive Pulmonary Disease.结核病相关慢性阻塞性肺疾病的发病率及危险因素
Int J Chron Obstruct Pulmon Dis. 2025 Jun 26;20:2091-2102. doi: 10.2147/COPD.S523732. eCollection 2025.
2
Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.针对慢性阻塞性肺疾病急性加重的简短患者教育行动计划。
Cochrane Database Syst Rev. 2016 Dec 19;12(12):CD005074. doi: 10.1002/14651858.CD005074.pub4.
3
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.慢性阻塞性肺疾病成人患者的预防性抗生素治疗:一项网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD013198. doi: 10.1002/14651858.CD013198.pub2.
4
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
5
Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.慢性阻塞性肺疾病的长效吸入疗法(β受体激动剂、抗胆碱能药物和类固醇):一项网状荟萃分析。
Cochrane Database Syst Rev. 2014 Mar 26;2014(3):CD010844. doi: 10.1002/14651858.CD010844.pub2.
6
Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).溴化乌美溴铵对比安慰剂用于慢性阻塞性肺疾病(COPD)患者。
Cochrane Database Syst Rev. 2017 Jun 20;6(6):CD011897. doi: 10.1002/14651858.CD011897.pub2.
7
Self-management interventions for people with chronic obstructive pulmonary disease.针对慢性阻塞性肺疾病患者的自我管理干预措施。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD002990. doi: 10.1002/14651858.CD002990.pub4.
8
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.噻托溴铵与长效β受体激动剂治疗稳定期慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009157. doi: 10.1002/14651858.CD009157.pub2.
9
Prevalence and Associated Factors of Chronic Obstructive Pulmonary Disease Among Adults in Neno District, Malawi: A Cross-Sectional Analytical Study.马拉维涅罗区成年人慢性阻塞性肺疾病的患病率及相关因素:一项横断面分析研究。
Int J Chron Obstruct Pulmon Dis. 2024 Feb 5;19:389-401. doi: 10.2147/COPD.S444378. eCollection 2024.
10
[Comparison of lung function and inflammatory markers and analysis of risk factors for acute exacerbations in patients with chronic obstructive pulmonary disease and persistent airflow limitation asthma].[慢性阻塞性肺疾病和持续性气流受限哮喘患者肺功能与炎症标志物的比较及急性加重危险因素分析]
Zhonghua Yi Xue Za Zhi. 2025 Jun 24;105(24):1981-1988. doi: 10.3760/cma.j.cn112137-20250208-00278.

本文引用的文献

1
Unveiling mechanisms of lung aging in COPD: A promising target for therapeutics development.揭示慢性阻塞性肺疾病中肺衰老的机制:治疗学发展的一个有前景的靶点。
Chin Med J Pulm Crit Care Med. 2024 Sep 17;2(3):133-141. doi: 10.1016/j.pccm.2024.08.007. eCollection 2024 Sep.
2
Associations of prior pulmonary tuberculosis with the incident COPD: a prospective cohort study.既往肺结核与 COPD 发病的相关性:一项前瞻性队列研究。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241239455. doi: 10.1177/17534666241239455.
3
Increased Risk of Incident Chronic Obstructive Pulmonary Disease and Related Hospitalizations in Tuberculosis Survivors: A Population-Based Matched Cohort Study.
肺结核幸存者发生慢性阻塞性肺疾病及相关住院的风险增加:基于人群的匹配队列研究。
J Korean Med Sci. 2024 Mar 25;39(11):e105. doi: 10.3346/jkms.2024.39.e105.
4
Fleischner Society: Glossary of Terms for Thoracic Imaging.美国胸科学会:胸部影像学术语词汇表。
Radiology. 2024 Feb;310(2):e232558. doi: 10.1148/radiol.232558.
5
An acidic microenvironment in Tuberculosis increases extracellular matrix degradation by regulating macrophage inflammatory responses.在结核病中,酸性微环境通过调节巨噬细胞炎症反应增加细胞外基质降解。
PLoS Pathog. 2023 Jul 7;19(7):e1011495. doi: 10.1371/journal.ppat.1011495. eCollection 2023 Jul.
6
Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease.肺结核导致肺损伤的机制:对慢性阻塞性肺疾病的影响。
Front Cell Infect Microbiol. 2023 Jun 21;13:1146571. doi: 10.3389/fcimb.2023.1146571. eCollection 2023.
7
Recent Prevalence of and Factors Associated With Chronic Obstructive Pulmonary Disease in a Rapidly Aging Society: Korea National Health and Nutrition Examination Survey 2015-2019.近年来快速老龄化社会中慢性阻塞性肺疾病的流行情况及相关因素:韩国 2015-2019 年国家健康和营养调查。
J Korean Med Sci. 2023 Apr 10;38(14):e108. doi: 10.3346/jkms.2023.38.e108.
8
Profile of patients with post-tuberculosis bronchiectasis in a tertiary care hospital in Brazil.巴西一家三级护理医院中肺结核后支气管扩张患者的概况。
J Clin Tuberc Other Mycobact Dis. 2022 Nov 13;29:100339. doi: 10.1016/j.jctube.2022.100339. eCollection 2022 Dec.
9
Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission.迈向消除慢性阻塞性肺疾病:柳叶刀委员会报告。
Lancet. 2022 Sep 17;400(10356):921-972. doi: 10.1016/S0140-6736(22)01273-9. Epub 2022 Sep 5.
10
Characterisation of the post-tuberculous phenotype of bronchiectasis: A real-world observational study.支气管扩张症的结核后表型特征:一项真实世界观察性研究。
Chron Respir Dis. 2022 Jan-Dec;19:14799731221098714. doi: 10.1177/14799731221098714.